Select Page

Author: Randy Roberie

IL-23 Inhibitors Show Highest Drug Survival in Psoriasis

TOPLINE: Interleukin (IL)-23p19 inhibitors guselkumab and risankizumab demonstrated the highest drug survival for effectiveness and safety comparable with ustekinumab over 2 years, exceeding that of all other biologics. IL-17 receptor inhibitor brodalumab showed comparable effectiveness and safety with adalimumab and secukinumab. METHODOLOGY: Researchers conducted a cohort study using data from the British Association of Dermatologists

Read More

How Google Chrome is declaring war against ad blockers

I’ve written a lot about ad blockers in the last few weeks, from Google’s Chrome updates making some popular options inoperable, to alternatives that will work, to my reason for blocking every ad on YouTube. So when I was contacted by representatives from Ghostery, a German company that operates an ad-blocker extension and other privacy

Read More